NCT06750328Not yet recruiting
Outcomes of Isolated LCx Occlusion
Procedural and Clinical Outcomes of Isolated Left Circumflex Coronary Artery Acute Occlusion in Patients Undergoing Primary Percutaneous Coronary Intervention
Source: ClinicalTrials.gov · Last updated 27 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To assess procedural success and short term clinical outcomes of primary PCI to isolated LCx acute occlusion.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 16 Dec 2024
- Start date
- 16 Dec 2024
- Primary completion date
- 12 Dec 2025
- Lead sponsor
- Assiut University
- Diseases
- Coronary artery disease
- NCT number
- NCT06750328
What you commit to
- Study type: Observational
- Planned participants: 50
- From 16 Dec 2024 to the primary completion date, 12 Dec 2025
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- -Patients with cardiogenic shock, NYHA class III-IV and multivessel coronary artery disease will be excluded.
Who the study is looking for
- Patients presented to Assiut University heart hospital with STEMI who underwent primary PCI that revealed isolated LCx acute occlusion (single culprit artery) between January 2018 to January 2025 will be included.
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.